Literature DB >> 8557699

Monocyte chemotactic factor in rheumatoid arthritis synovial tissue. Probably a cross-linked derivative of S19 ribosomal protein.

H Nishiura1, Y Shibuya, S Matsubara, S Tanase, T Kambara, T Yamamoto.   

Abstract

The extracts of rheumatoid arthritis-synovial lesions from seven patients possessed a strong chemotactic activity for monocytes and a negligible one for polymorphonuclear leukocytes. These results are consistent with a prominent histological feature of the synovial lesion, the mononuclear cell predominant infiltration. The major monocyte chemotactic factor in the synovial tissue extracts was purified to a single protein peak in reverse phase high performance liquid chromatography with a C4 column. NH2-terminal amino acid analysis of the initial 20 residues yielded a single sequence. Surprisingly, this sequence was completely identical to that of S19 ribosomal protein. The purified sample demonstrated two protein bands in SDS-polyacrylamide gel electrophoresis with apparent molecular masses of 34 and 68 kDa. These sizes were 2 and 4 times that of S19 ribosomal protein, suggesting that the chemotactic factor would be a dimer or tetramer of S19 ribosomal protein cross-linked by factor XIIIa. A recombinant human S19 ribosomal protein was prepared as a fusion protein with a maltose binding protein in Escherichia coli. After treatment with factor XIIIa, cross-linked recombinant S19 ribosomal protein exhibited the monocyte chemotactic activity, although the untreated recombinant protein did not.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557699     DOI: 10.1074/jbc.271.2.878

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signals.

Authors:  Rong Yang; Gabrielle Fredman; Sriram Krishnamoorthy; Nitin Agrawal; Daniel Irimia; Daniele Piomelli; Charles N Serhan
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

2.  Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion.

Authors:  Lei Shi; Shigeyuki Tsurusaki; Noriko Futa; Tamami Sakamoto; Tomoko Matsuda; Norikazu Nishino; Ryuji Kunitomo; Michio Kawasuji; Kazutaka Tokita; Tetsuro Yamamoto
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

3.  Impaired ribosome biogenesis in Diamond-Blackfan anemia.

Authors:  Valérie Choesmel; Daniel Bacqueville; Jacques Rouquette; Jacqueline Noaillac-Depeyre; Sébastien Fribourg; Aurore Crétien; Thierry Leblanc; Gil Tchernia; Lydie Da Costa; Pierre-Emmanuel Gleizes
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

4.  Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer.

Authors:  Y Shibuya; M Shiokawa; H Nishiura; T Nishimura; N Nishino; H Okabe; K Takagi; T Yamamoto
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

5.  The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1.

Authors:  Maciej M Markiewski; Surya Kumari Vadrevu; Sharad K Sharma; Navin Kumar Chintala; Shanawaz Ghouse; Jun-Hung Cho; David P Fairlie; Yvonne Paterson; Aristotelis Astrinidis; Magdalena Karbowniczek
Journal:  J Immunol       Date:  2017-02-22       Impact factor: 5.422

6.  A plasma protein indistinguishable from ribosomal protein S19: conversion to a monocyte chemotactic factor by a factor XIIIa-catalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation.

Authors:  Umeko Semba; Jun Chen; Yoshihiko Ota; Nan Jia; Hidetoshi Arima; Hiroshi Nishiura; Tetsuro Yamamoto
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

Review 7.  Targeting complement-mediated immunoregulation for cancer immunotherapy.

Authors:  Martin Kolev; Maciej M Markiewski
Journal:  Semin Immunol       Date:  2018-02-15       Impact factor: 11.130

8.  Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function.

Authors:  Ana-Maria Filip; Jörg Klug; Sevil Cayli; Suada Fröhlich; Tamara Henke; Philipp Lacher; Regina Eickhoff; Patrick Bulau; Monika Linder; Christine Carlsson-Skwirut; Lin Leng; Richard Bucala; Sandra Kraemer; Jürgen Bernhagen; Andreas Meinhardt
Journal:  J Biol Chem       Date:  2009-01-20       Impact factor: 5.157

9.  Pro- and anti-apoptotic dual functions of the C5a receptor: involvement of regulator of G protein signaling 3 and extracellular signal-regulated kinase.

Authors:  Hiroshi Nishiura; Hideo Nonaka; Ivette S Revollo; Umeko Semba; Ying Li; Yoshihiko Ota; Atsushi Irie; Kumiko Harada; John H Kehrl; Tetsuro Yamamoto
Journal:  Lab Invest       Date:  2009-03-30       Impact factor: 5.662

10.  Switch moiety in agonist/antagonist dual effect of S19 ribosomal protein dimer on leukocyte chemotactic C5a receptor.

Authors:  Arjun Shrestha; Megumi Shiokawa; Takumasa Nishimura; Hiroshi Nishiura; Yuji Tanaka; Norikazu Nishino; Yoko Shibuya; Tetsuro Yamamoto
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.